Pevion Biotech AG
Records under this name other than patents Pevion Biotech AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Pevion Biotech AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,852,604 | Multiepitope Vaccine for Her2/Neu-Associated Cancers Formerly held Lapsed on the fee record Ended Oct 7, 2026 · High confidence | Lapsed on the fee record | Ended Oct 7, 2026 | High confidence |
| US 9,610,334 | Truncated secretory aspartyl proteinase 2 Formerly held Lapsed on the fee record Ended Apr 4, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | USPTO record |
| US 8,715,698 | Truncated secretory aspartyl proteinase 2 Formerly held Lapsed on the fee record Ended May 6, 2022 · USPTO record | Lapsed on the fee record | Ended May 6, 2022 | USPTO record |
| US 8,372,963 | RSV F-protein and its use Lapsed on the fee record Ended Feb 12, 2021 · USPTO record | Lapsed on the fee record | Ended Feb 12, 2021 | USPTO record |
| US 8,367,077 | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof Lapsed on the fee record Ended Feb 5, 2021 · USPTO record | Lapsed on the fee record | Ended Feb 5, 2021 | USPTO record |